Get started
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class HGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class HGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H

No trades
See on Supercharts
OverviewFinancialsNewsDiscussionsForecastSeasonalsETFs

GU5 chart


Full chart

GU5 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.74 B‬ EUR
Dividend yield (indicated)
4.81%
Price to earnings Ratio (TTM)
9.67
Basic EPS (TTM)
0.20 EUR
Net income (FY)
‪382.14 M‬ EUR
Revenue (FY)
‪10.08 B‬ EUR
Shares float
‪219.90 M‬
Beta (1Y)
0.63

Employees


Employees (FY)
‪28.14 K‬
Change (1Y)
+90 +0.32%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Hong Li
Website
gybys.com.cn
Headquarters
Guangzhou
Founded
1997
ISIN
CNE100000387
FIGI
BBG000BGYYR0
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. engages in the manufacture, wholesale, retail, import, and export of pharmaceutical products, medical apparatus, and Chinese medicine. It operates in the following segments: Great Southern Traditional Chinese Medicine (TCM), Great Health, Great Commerce, and Other. The Great Southern TCM segment provides research, development, manufacturing, and sales for Chinese and Western medicine. The Great Health segment refers to the research, development, manufacturing, and sales for the products of Great Health. The Great Commerce segment relates to the wholesale, retail, import, and export for Western medicine, Chinese medicine, and medical apparatus and instruments. The Other segment is involved in other manufacturing and distributing traditional Chinese medicines activities. The company was founded on September 1, 1997 and is headquartered in Guangzhou, China.

Check out other big names from the same industry as GU5.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GU5 news



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H stocks are traded under the ticker GU5.
We've gathered analysts' opinions on Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H future price: according to them, GU5 price has a max estimate of 2.53 EUR and a min estimate of 1.60 EUR. Watch GU5 chart and read a more detailed Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H stock forecast: see what analysts think of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H and suggest that you do with its stocks.
GU5 reached its all-time high on May 2, 2019 with the price of 4.58 EUR, and its all-time low was 1.20 EUR and was reached on Dec 3, 2012. View more price dynamics on GU5 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H financials in yearly and quarterly reports right on TradingView.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H is going to release the next earnings report on Oct 28, 2025. Keep track of upcoming events with our Earnings Calendar.
GU5 net income for the last quarter is ‪81.06 M‬ EUR, while the quarter before that showed ‪231.28 M‬ EUR of net income which accounts for −64.95% change. Track more Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H financial stats to get the full picture.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H dividend yield was 4.83% in 2024, and payout ratio reached 46.45%. The year before the numbers were 3.78% and 29.85% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 2, 2025, the company has ‪28.14 K‬ employees. See our rating of the largest employees — is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H EBITDA is ‪451.15 M‬ EUR, and current EBITDA margin is 5.73%. See more stats in Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H financial statements.
Like other stocks, GU5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H stock right from TradingView charts — choose your broker and connect to your account.